Search Results 1391-1400 of 11394 for anti-TNF drugs

  1. Rectal Cancer Clinical Trials - Mayo Clinic Research

    Fluorouracil and leucovorin are drugs approved for the treatment of mCRC. ... therapy selection tool for systemic therapy ... anti-tumor activity. Gemini Study To ...

  2. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

    APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis. Print details. Share ...

  3. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... Are anti-HBc positive, HBsAg negative, and have ...

  4. Plasma Cell Disorders Clinical Trials - Mayo Clinic Research

    ... therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. ... drugs for the treatment of a blood cancer called multiple myeloma.

  5. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy In Previously Treated Advanced Or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations Or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... and Hepatitis C virus (defined as anti-HCV Ab positive and detectable ...

  6. Onvansertib For The Treatment Of Recurrent Or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.

  7. Clinical trials - Oncology (Medical)

    ... treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti ...

  8. Nadolol and bendroflumethiazide (oral route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Hematology - Clinical trials

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  10. Mediated Amyloidosis In Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) - Mayo Clinic

    The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis In Patients Who Have Already Been ...